Clinical Trial · NCT04689048

Characterization of Large Brain Metastases With 18F-Fluciclovine PET/CT Treated With Staged Stereotactic Radiosurgery

Overview

The spread of cancer to the brain is referred to as brain metastases. Brain metastases are a common complication of cancer. This study is being done to determine whether the use of a new imaging agent, 18F-fluciclovine, is able to detect which patients are responding to radiation therapy. In addition, this study will look at the changes of the treated brain metastases using this imaging agent over time.

Sponsor

Baptist Health South Florida

Phase

Phase 1

Contacts

Rupesh C Kotecha, MD (Principal Investigator)

rupeshk@baptisthealth.net

17865962000

Maria C Avendano

mariaave@baptisthealth.net

17865962000

ClinicalTrials.gov

NCT04689048

Drug / Compound

Isotope(s):
Target(s):